Europe Montelukast API Market was valued at USD 0.7 Billion in 2022 and is projected to reach USD 1.1 Billion by 2030, growing at a CAGR of 6.3% from 2024 to 2030.
The Montelukast Active Pharmaceutical Ingredient (API) market in Europe is seeing significant growth, driven by the increasing demand for asthma and allergy medications. As a key ingredient in Montelukast, a drug primarily used to treat asthma and seasonal allergies, the Montelukast API is essential for both large-scale pharmaceutical production and the growing need in respiratory therapies. Industries, particularly in the healthcare and pharmaceutical sectors, are relying on Montelukast API to meet the rising healthcare demands for effective allergy and asthma management solutions.
Montelukast is a leukotriene receptor antagonist that works by blocking substances in the body known as leukotrienes, which cause the airways to swell and tighten. Its use is widespread among patients with chronic asthma, seasonal allergic rhinitis, and other related respiratory conditions. The increasing prevalence of asthma in Europe, combined with the rise in allergy-related disorders, has fueled the market for Montelukast API.
In Europe, the pharmaceutical industry requires high-quality Montelukast API to manufacture effective treatments. This API is produced under strict regulations to ensure safety and efficacy, as the drug plays a pivotal role in managing asthma and allergies. Europe’s pharmaceutical manufacturing plants rely on bulk Montelukast API to meet both prescription and over-the-counter medication demands. Additionally, industries involved in research and development for new asthma treatments or combination therapies are seeking higher quality APIs, pushing the market forward.
The European market is also being influenced by the increasing demand for generic versions of Montelukast, following the expiration of patents. This shift is causing pharmaceutical companies to seek cost-effective sources for Montelukast API, while still maintaining high standards of quality and compliance. Additionally, the growing healthcare spending and increasing patient awareness about asthma treatments have added to the demand for Montelukast API in both private and public healthcare systems.
Furthermore, the Montelukast API market in Europe is seeing a rise in collaborations between pharmaceutical manufacturers and API suppliers. These collaborations are aimed at ensuring the consistent supply of high-quality Montelukast API and addressing market demands. This trend is expected to continue as Montelukast remains one of the most prescribed drugs for asthma and allergic rhinitis.
Ultimately, the Montelukast API market is positioned for substantial growth, influenced by ongoing research, market competition, and the increasing demand from both the pharmaceutical industry and healthcare providers in Europe. The need for innovative and cost-efficient solutions in the treatment of respiratory conditions is driving this growth, with Montelukast API at the forefront.
Get an In-Depth Research Analysis of the Europe Montelukast API Market Size And Forecast [2025-2032]
Merck
Cipla
Morepen Laboratories
Sun Pharma
Teva Pharmaceutical Industries
Intas Pharmaceuticals
Apotex
Sanyo Chemical Industries
Mylan
Delmar Chemicals
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Europe Montelukast API Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Europe Montelukast API Market
Tablets
Granules
Syrups
Inhalation solutions
Oral
Inhalation
Intranasal
Asthma Treatment
Allergic Rhinitis
Exercise-Induced Bronchoconstriction
Chronic Obstructive Pulmonary Disease (COPD)
Hospitals
Pharmacies
Homecare Settings
Specialized Clinics
Direct Sales
Distributors
Online Pharmacies
Retail Pharmacies
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Montelukast API Market Research Analysis
1. Introduction of the Europe Montelukast API Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Europe Montelukast API Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Europe Montelukast API Market, By Type
6. Europe Montelukast API Market, By Application
7. Europe Montelukast API Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. Europe Montelukast API Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Europe Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/